Bioline Rx reported $-1.6M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
Bio Path USD -976K 3.62M Sep/2025
Bioline Rx USD -1.6M 635K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025